News in the Life Sciences Industry

BEIJING, Feb. 22, 2019 /PRNewswire/ -- The Forum for the National Mega Innovation Program in conjunction with the press conference on the launch of Tyvyt(®) (fully human anti-PD-1 therapeutic monoclonal antibody, generic name: sintilimab injection), hosted by Innovent Biologics, Inc. (Innovent)... Read more ››

BENGALURU, February 22, 2019 /PRNewswire/ --

MUMBAI, India, February 21, 2019 /PRNewswire/ --

Biotechnology innovation and people-centric partnerships will be key to harness lucrative growth prospects, finds Frost & Sullivan

TEL AVIV, Israel, Feb 13, 2019 /CNW/ -- The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the markets in which these companies operate, thus creating appropriate pricing and increasing the exposure of investors... Read more ››

BiolineRx announced both a $15 million ADS offering and a new Orphan Drug Designation by the FDA for its lead oncology product, BL-8040 for the treatment of pancreatic cancer. The company's value has increased to $197M

SUZHOU, China, Feb. 7, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and other major diseases, today announced... Read more ››

Enhanced connectivity capabilities and vendor-agnostic solutions to drive next-generation POCT, finds Frost & Sullivan